Experience

CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion

January 10, 2023

Cooley advised CinCor Pharma, a clinical-stage biopharmaceutical company, on its definitive agreement to be acquired by AstraZeneca. M&A partners Rama Padmanabhan and Rowook Park and corporate partners Div Gupta and Sarah Sellers led the Cooley team.

Read more

Related contacts

Rowook Park
Partner, San Diego
Rama Padmanabhan
Partner, San Diego
Div Gupta
Partner, New York
Sarah Sellers
Partner, New York
Christophe Beauduin
Special Counsel, New York
Benjamin “Izzy” Lubarsky
Associate, New York
Alessandra Murata
Partner, Palo Alto
Ajay Athavale
Associate, San Francisco
Megan Drill
Associate, San Diego
Melissa Meza
Associate, San Diego
Trey Reilly
Associate, New York
Amy Hallman Rice
Special Counsel, San Diego
Matthew D. Silverman
Special Counsel, San Diego
Howard Morse
Partner, Washington DC
Sharon Connaughton
Special Counsel, Washington DC
Rubin Waranch
Associate, Washington DC
Natasha Leskovsek
Of Counsel, Washington DC
Phil Mitchell
Partner, New York
Charity Williams
Partner, San Diego
MaryBeth Shreiner
Associate, Reston
Elizabeth Lewis
Senior Counsel, Washington DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Patrick Sharma
Associate, Los Angeles Santa Monica
Karen Tsai
Special Counsel, Washington DC
Heidi A. Erlacher
Partner in Charge – Boston, Boston
Kristopher Kleiner
Special Counsel, Colorado
Ryan Sansom
Partner, Boston
Stephanie Gentile
Partner, New York
Aric Wu
Partner, New York
Christopher Kimball
Partner, Washington DC
Nyron J. Persaud
Partner, New York
Helenanne Connolly
Partner, Reston
Stella Sarma
Special Counsel, Brussels
Stella Sarma
Special Counsel, Brussels
Stacey A. Bradford
Special Counsel, Washington DC
Christine Graham
Special Counsel, London
Dillon Martinson
Special Counsel, Washington DC
Lindsey O'Crump
Associate, Washington DC
Vivian Tsai
Associate, Los Angeles Santa Monica
Arman Sagart
Associate, San Diego
Daniel Gillon
Associate, San Diego
Barry Kuang
Associate, Boston
Rajdeep Roger Bains
Associate, San Diego
Alexander Fullman
Associate, New York
Amanda Gonzalez Burton
Associate, New York
Grace Hunter
Associate, Washington DC
Kindall G. Jackson
Associate, Washington DC
Dr. Xixi Sun
Associate, Boston
Sarah Curry
Associate, New York
Carly Mitchell
Associate, Washington DC
Jennifer Shanley
Special Counsel, New York
Wyatt Kernell
Associate, New York
Allison Kutner
Associate, New York

Oyster Point Pharma to Be Acquired by Viatris

November 10, 2022

Cooley advised Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, on its definitive agreement to be acquired by global healthcare company Viatris. Partners Mika Reiner Mayer, Brandon Fenn, Div Gupta and Ian Nussbaum led the Cooley team advising Oyster Point Pharma.

Read more

Related contacts

Mika Reiner Mayer
Partner, Palo Alto
Brandon W. Fenn
Partner, New York
Div Gupta
Partner, New York
Sarah Lightdale
Partner, New York
Eileen Marshall
Partner, Washington DC
Howard Morse
Partner, Washington DC
John Paul Oleksiuk
Partner, New York
Nyron J. Persaud
Partner, New York
John Robertson
Partner in Charge – Seattle, Seattle
Charity Williams
Partner, San Diego
Natasha Leskovsek
Of Counsel, Washington DC
Ryan Montgomery
Special Counsel, Boston
Thomas Welk
Senior Counsel, San Diego
Nathan Baum
Associate, New York
Kimberly Bolin
Patent Agent, Palo Alto
Julia R. Brinton
Associate, Washington DC
Cara Buchicchio
Associate, New York
Colette Ghazarian
Associate, Los Angeles Downtown
Liz Gold
Associate, New York
Amanda Griggs
Associate, New York
Edward (Teddy) Nimetz
Associate, New York
Ryan Walker
Associate, New York

Karuna Therapeutics – $862.5 Million Follow-on Offering

September 7, 2022

Cooley advised the underwriters in Karuna Therapeutics’ $862.5 million follow-on offering of 4,011,628 shares of common stock at a public offering price of $215 per share. Karuna is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. Partners Richard Segal, Jean Park, Div Gupta and associate Darah Protas led the Cooley team.

Related contacts

Richard Segal
Partner, New York
Jean Park
Partner, New York
Div Gupta
Partner, New York
Darah Protas
Associate, Washington DC
Charles York
Associate, New York
Katie Lapidus
Associate, Washington DC
Quay Strozier
Associate, Washington DC
Katherine King
Associate, Washington DC

Silence Therapeutics – $56.5 Million Registered Direct Offering

September 7, 2022

Cooley advised Silence Therapeutics in a $56.5 million registered direct offering of 5,950,000 American Depositary Shares (ADS), each representing three ordinary shares, at a price of $9.50 per ADS. Silence is a biotechnology company focused on discovering and developing molecules incorporating novel short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with significant unmet medical need. Partners Josh Kaufman, Div Gupta, Nicolas H.R. Dumont and Claire Keast-Butler led the Cooley team.

Related contacts

Josh Kaufman
Partner, New York
Div Gupta
Partner, New York
Nicolas H.R. Dumont
Partner, New York
Claire Keast-Butler
Partner, London
Sam Meiklejohn
Associate, London
Giovanna Robledo
Associate, New York

Cerevel Therapeutics – $253.8 Million Follow-on Offering and Concurrent $345.0 Million Rule 144A Convertible Notes Offering

September 2, 2022

Cooley advised the underwriters in Cerevel Therapeutics’ $253.8 million follow-on offering of 7,250,000 shares of its common stock at a public offering price of $35 per share and the initial purchasers in its $345.0 million Rule 144A convertible notes offering. Cerevel is a clinical-stage biopharmaceutical company pursuing a targeted approach to neuroscience that combines a deep understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system target receptor selective pharmacology to discover and design new therapies. Lawyers Div Gupta, Daniel Goldberg, Eric Blanchard, Mischi a Marca, Jason Savich, Minkyu Park, Amiti Rothstein, Ellie Guadiana, Matt Kong, Eric Delgado and Jordan Verrilli led the Cooley team.

Related contacts

Div Gupta
Partner, New York
Daniel I. Goldberg
Partner, New York
Eric Blanchard
Partner, New York
Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Minkyu Park
Associate, New York
Amiti C. Rothstein
Associate, New York
Ellie Guadiana
Partner, Los Angeles Santa Monica
Matt Kong
Associate, San Francisco
Eric J. Delgado
Associate, New York
Kindall G. Jackson
Associate, Washington DC
View more

Rankings & accolades

Chambers USA: Capital Markets - Nationwide (Eastern United States) (2020 – 2022)

Chambers USA: Life Sciences: Corporate/Commercial - Nationwide (2022)

Legal 500: Key Lawyer - Capital Markets: Equity Offerings and Healthcare: Life Sciences (2020 – 2021)

Law 360 Rising Star (2015)

Who's Who Legal: Life Sciences (2018)

highly regarded for his experience assisting life sciences companies on IPOs and other capital markets matters

Divakar is excellent in supporting our company.

Chambers USA: Life Sciences: Corporate/Commercial 

Nationwide (2022)